Phase I/II trial of cancer vaccine E75 (NeuVax) for the prevention of disease recurrence in patients with HER2-positive prostate cancer.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 04 Jul 2008
At a glance
- Drugs Nelipepimut-S (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 04 Jul 2008 New trial record.
- 02 Jun 2008 Five-year follow-up data presented at the American Society of Clinical Oncology (ASCO) 2008.